A genetic link between schizophrenia and autism is enabling researchers to study the effectiveness of drugs used to treat both illnesses.
25 February, 2010
The Gastrointestinal Drugs Advisory Committee of the FDA has recommended the approval of XIFAXAN® (rifaximin) tablets (550 mg) for the maintenance of remission of hepatic encephalopathy.
24 February, 2010
Researchers have discovered a protein crucial in mediating the anti-inflammatory actions of nuclear lipid receptors. The findings create new possibilities for treating metabolic diseases associated with inflammation, such as diabetes.
19 February, 2010
Researchers have uncovered how cells ensure inheritance of their genetic information in order to prevent diseases.
17 February, 2010
Researchers have established a link between deprivation and the p53 gene that explains why women from poorer backgrounds are less likely to survive breast cancer.
16 February, 2010
Scientists working at the University of Dundee have discovered a form of stem cell activity that might help lead to the early identification of cancer.
12 February, 2010
A study in BMC Neuroscience has shown that chocolate-craving mice will tolerate electric shocks to get their fix.
11 February, 2010
Silence Therapeutics announced recently that the United States Patent and Trademark Office has issued them a notice of allowance on a patent application covering a novel cancer target.
10 February, 2010
UK cancer patients to gain access to the latest robotic radiosurgery treatments with the announcement that the Clatterbridge Centre for Oncology has ordered the country’s first Novalis Tx™ radiosurgery platform.
09 February, 2010
A centre created by the Medical Research Council (MRC) and MRC Technology to fast-track the discovery and development of novel drugs opened its first call for targets recently.
08 February, 2010
Xiaflex has recently been approved to treat progressive hand disease Dupuytren's contracture, which can affect a person’s ability to straighten and use their fingers.
05 February, 2010
BioFine Europe 2010 will take place from 30–31 March and features The Peptide Conference 2010, the Synthetic Biology in Pharma conference and the BioFine Europe Exhibition.
03 February, 2010
Novo Nordisk has announced that the FDA has granted marketing authorization for Victoza® for the treatment of type 2 diabetes in adults.
02 February, 2010
A drug safety warning from the MHRA on the dangers of switching immunosuppressants calls into question the safety of the Department of Health’s proposal for Automatic Generic Substitution.
01 February, 2010